<DOC>
	<DOCNO>NCT00004334</DOCNO>
	<brief_summary>OBJECTIVES : I . Study relationship dysregulation hypothalamic-pituitary-adrenal ( HPA ) axis disorder mood , vegetative function , cognition patient Cushing 's disease . II . Identify subgroups patient Cushing 's disease differ presence severity depressive syndrome , uncover HPA axis dysregulation difference among use corticotropin-releasing hormone , metyrapone , dexamethasone challenge testing .</brief_summary>
	<brief_title>Study Depression , Peptides , Steroids Cushing 's Syndrome</brief_title>
	<detailed_description>PROTOCOL OUTLINE : All patient receive psychiatric evaluation baseline , well assessment plasma adrenocorticotropin , beta lipotropin , beta endorphin , cortisol , urinary cortisol . Peptide steroid assay perform , alone response corticotropin-releasing hormone , metyrapone , dexamethasone . Patients give sleep electroencephalogram baseline 1 year follow treatment . A weight maintenance diet prescribed patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cushing Syndrome</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Patients age 20 60 spontaneous active Cushing 's syndrome At least 2 week since medication psychoactive effect influence cortisol metabolism hepatic hydroxylating enzyme induction Antihypertensives allow severe hypertension No barbiturates No phenytoin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>Cushing 's syndrome</keyword>
	<keyword>endocrine disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>